We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$4.21M
Cap. Flow
-$36.2M
Cap. Flow %
-3.4%
Top 10 Hldgs %
45.51%
Holding
2,874
New
227
Increased
1,384
Reduced
630
Closed
115

Top Sells

Rank Stock Value
1
OCSL icon
Oaktree Specialty Lending
OCSL
+$12.7M
2
NVDA icon
NVIDIA
NVDA
+$6.29M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.66M
4
AAPL icon
Apple
AAPL
+$3.19M
5
AVGO icon
Broadcom
AVGO
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 12.25%
3 Healthcare 6.29%
4 Communication Services 4.39%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTRG icon
951
Essential Utilities
WTRG
$11.4B
$35.1K ﹤0.01%
939
+3
+0.3% +$111
PARA
952
DELISTED
Paramount Global Class B
PARA
$35K ﹤0.01%
3,370
+751
+29% +$8.8K
QSR icon
953
Restaurant Brands International
QSR
$25.8B
$35K ﹤0.01%
497
-27
-5% -$1.93K
KW
954
DELISTED
Kennedy-Wilson Holdings
KW
$35K ﹤0.01%
3,596
+1,758
+96% +$16.4K
CPT icon
955
Camden Property Trust
CPT
$11.3B
$34.9K ﹤0.01%
320
+42
+15% +$4.34K
FMX icon
956
Fomento Económico Mexicano
FMX
$41.7B
$34.9K ﹤0.01%
324
-15
-4% -$1.75K
APG icon
957
APi Group
APG
$18B
$34.8K ﹤0.01%
1,389
+138
+11% +$3.46K
CATY icon
958
Cathay General Bancorp
CATY
$4.24B
$34.7K ﹤0.01%
921
-113
-11% -$4.1K
FPE icon
959
First Trust Preferred Securities and Income ETF
FPE
$6.36B
$34.7K ﹤0.01%
2,000
INSM icon
960
Insmed
INSM
$28.6B
$34.7K ﹤0.01%
518
+91
+21% +$3.53K
TPR icon
961
Tapestry
TPR
$32.8B
$34.7K ﹤0.01%
811
+217
+37% +$9.07K
NYT icon
962
New York Times
NYT
$10.2B
$34.7K ﹤0.01%
677
+434
+179% +$20.4K
BV icon
963
BrightView Holdings
BV
$1.07B
$34.6K ﹤0.01%
2,605
+35
+1% +$446
X
964
DELISTED
US Steel
X
$34.3K ﹤0.01%
907
+36
+4% +$1.37K
RSP icon
965
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$34.2K ﹤0.01%
208
MTTR
966
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$34.2K ﹤0.01%
7,641
+2,006
+36% +$7.6K
ESS icon
967
Essex Property Trust
ESS
$18.5B
$34K ﹤0.01%
125
-5
-4% -$1.28K
LONA
968
LeonaBio Inc
LONA
$72.1M
$33.8K ﹤0.01%
1,274
BPMC
969
DELISTED
Blueprint Medicines
BPMC
$33.7K ﹤0.01%
313
-38
-11% -$3.8K
TAK icon
970
Takeda Pharmaceutical
TAK
$55.7B
$33.6K ﹤0.01%
2,595
-1,800
-41% -$23.8K
NTNX icon
971
Nutanix
NTNX
$16.9B
$33.5K ﹤0.01%
590
+27
+5% +$1.66K
ESAB icon
972
ESAB
ESAB
$5.71B
$33.5K ﹤0.01%
355
-47
-12% -$4.88K
CMRE icon
973
Costamare
CMRE
$1.77B
$33.4K ﹤0.01%
2,035
+124
+6% +$1.69K
ATKR icon
974
Atkore
ATKR
$3.16B
$33.2K ﹤0.01%
246
+7
+3% +$1.11K
ARKK icon
975
ARK Innovation ETF
ARKK
$6.29B
$33.2K ﹤0.01%
755

Similar funds

Lindbrook Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Lindbrook Capital held 2,874 positions worth $1.06B, down 0.39% from $1.07B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital withdrew a net $36.2M in Q2 2024, closing 115 positions and reducing 630 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $1.24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lindbrook Capital opened a new position in Nuveen ESG Small-Cap ETF worth $323K.

  • Lindbrook Capital's largest Q2 2024 buy was Nuveen ESG Small-Cap ETF: 8,216 shares worth $323K.
  • Lindbrook Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $3.36M increase.
  • Lindbrook Capital's biggest Q2 2024 reduction was Oaktree Specialty Lending, cutting an estimated $12.7M.
  • Lindbrook Capital fully exited ProShares UltraPro QQQ in Q2 2024, selling an estimated $1.24M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $1.06B portfolio in Q2 2024.
  • Lindbrook Capital opened 227 new positions and closed 115 in Q2 2024.
  • Lindbrook Capital's portfolio value fell 0.39% quarter-over-quarter to $1.06B.

Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.